Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAR-T Cell Therapy in Relapsed/Refractory Autoimmune Diseases

NCT07193667 is registered in ClinicalTrials.gov with ShenZhen Cell Valley as lead sponsor.

NCT NCT07193667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07193667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAR-T Cell Therapy in Relapsed/Refractory Autoimmune Diseases
Lead sponsor
ShenZhen Cell Valley
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2025
Completion date
December 31, 2027
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory autoimmune diseases